Morgan Stanley Lowered the Firm's PT on UnitedHealth Group (UNH), Kept an Overweight Rating

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 13, Morgan Stanley lowered the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) from $374 to $324, while maintaining an Overweight rating on the stock.

The reduced price target comes as analysts believe that the new leadership will establish a conservative outlook for 2025 and 2026. The anticipated conservative outlook is due to the ongoing challenges with Optum and expected increases in investments. However, the analyst also foresees some recovery in Medicare Advantage margins by 2026, thereby keeping his Buy rating on the stock.

UnitedHealth Group Incorporated (NYSE:UNH) is a health care company that operates through two main business segments, including UnitedHealthcare and Optum.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.